Here are 18 key notes on orthopedic and spine device companies over the past week.
Spinal Tech
Claremont, Calif.-based Atlas Spinal Care now offers a new cervical radiculopathy treatment.
The U.S. minimally invasive spine fusion market is anticipated to surpass $1.15 billion by 2021, based on an iData Research report, according to Digital Journal.
Researchers presented data from the Walnut Creek, Calif.-based Providence Medical Technology's DTRAX system two-year study at Spine Week 2016 in Singapore, according to Digital Journal.
In the last trading session, St. Jude Medical shares rallied 0.32 percent, reaching $76.35, according to News Oracle.
The global hip and knee surgical implants market is anticipated to grow at a compound annual growth rate of 9.54 percent to 2022, according to Digital Journal.
Medtronic launched Spine Essentials in the United States at the Ambulatory Surgical Center Association annual meeting in Dallas.
Nintendo included health and medical devices in its updated Articles of Incorporations, according to MCV.
Salt Lake City-based Predictive Technology Group's Predictive Biotech beta launched its molecular diagnostic test for spinal deformities, according to Digital Journal.
Medtronic Spine President Douglas King wrote U.S. senators a letter stating the misplacement of data on its Infuse product was not intentional, according to a Minneapolis Star Tribune report.
